Stocks and Investing Stocks and Investing
Tue, May 26, 2020
Mon, May 25, 2020
Fri, May 22, 2020

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Increased Target to $15 on, May 22nd, 2020


Published on 2024-10-27 07:03:21 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Increased Target from $13 to $15 on, May 22nd, 2020.

Raghuram has made no other calls on AQST in the last 4 months.



There is 1 other peer that has a rating on AQST. Out of the 1 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram


  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $36 on, Monday, February 10th, 2020
Contributing Sources